ES307302A1 - Procedimiento para preparar nuevos 6,7-benzomorfanos sustituidos. - Google Patents

Procedimiento para preparar nuevos 6,7-benzomorfanos sustituidos.

Info

Publication number
ES307302A1
ES307302A1 ES0307302A ES307302A ES307302A1 ES 307302 A1 ES307302 A1 ES 307302A1 ES 0307302 A ES0307302 A ES 0307302A ES 307302 A ES307302 A ES 307302A ES 307302 A1 ES307302 A1 ES 307302A1
Authority
ES
Spain
Prior art keywords
lower alkyl
radical
general formula
formula
translation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0307302A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
JR Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JR Geigy AG filed Critical JR Geigy AG
Publication of ES307302A1 publication Critical patent/ES307302A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Discharge Lamp (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES0307302A 1963-12-20 1964-12-19 Procedimiento para preparar nuevos 6,7-benzomorfanos sustituidos. Expired ES307302A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33229663A 1963-12-20 1963-12-20

Publications (1)

Publication Number Publication Date
ES307302A1 true ES307302A1 (es) 1965-05-16

Family

ID=23297612

Family Applications (4)

Application Number Title Priority Date Filing Date
ES0307299A Expired ES307299A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de 6,7-benzomorfanos sustituidos.
ES0307300A Expired ES307300A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de nuevos 6,7-benzomorfanos sustituidos.
ES0307301A Expired ES307301A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de nuevos 6, 7-benzomorfanos sustituidos
ES0307302A Expired ES307302A1 (es) 1963-12-20 1964-12-19 Procedimiento para preparar nuevos 6,7-benzomorfanos sustituidos.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES0307299A Expired ES307299A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de 6,7-benzomorfanos sustituidos.
ES0307300A Expired ES307300A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de nuevos 6,7-benzomorfanos sustituidos.
ES0307301A Expired ES307301A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de nuevos 6, 7-benzomorfanos sustituidos

Country Status (12)

Country Link
AT (4) AT253687B (OSRAM)
BE (2) BE657405A (OSRAM)
CH (7) CH449639A (OSRAM)
DE (2) DE1445853A1 (OSRAM)
DK (4) DK106552C (OSRAM)
ES (4) ES307299A1 (OSRAM)
FR (2) FR4345M (OSRAM)
GB (2) GB1092394A (OSRAM)
IL (2) IL22642A (OSRAM)
NL (3) NL6414820A (OSRAM)
NO (2) NO119274B (OSRAM)
SE (2) SE322779B (OSRAM)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
EP1506174B1 (en) 2002-05-17 2015-09-30 Taiwanj Pharmaceuticals Co., Ltd. Use of naltrexone for treating kidney and liver damage
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
CA2678577A1 (en) 2007-02-26 2008-09-04 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
AR067673A1 (es) 2007-07-26 2009-10-21 Vitae Pharmaceuticals Inc Derivados de 1,3 oxazinan - 2 - ona como inhibidores ciclicos de la 11 beta -hidroxiesteroide deshidrogenasa 1. composiciones farmaceuticas.
AR069207A1 (es) 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
AR069545A1 (es) 2007-11-16 2010-02-03 Boehringer Ingelheim Pharma Derivados de aril y heteroarilcarbonilo de benzomorfanos y estructuras relacionadas, composiciones farmaceuticas que contienen dichos compuestos, obtencion de las mismas, su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa (hsd) 1 y
WO2009075835A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceutical, Inc CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
JP5490020B2 (ja) 2008-01-24 2014-05-14 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状カルバゼート及びセミカルバジドインヒビター
JP5734666B2 (ja) 2008-02-11 2015-06-17 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の1,3−オキサアゼパン−2−オン及び1,3−ジアゼパン−2−オン阻害剤
CA2711757C (en) * 2008-02-12 2016-07-26 Boehringer Ingelheim International Gmbh Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
WO2009102460A2 (en) 2008-02-15 2009-08-20 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2723039A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5538365B2 (ja) 2008-05-01 2014-07-02 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
JP5451752B2 (ja) 2008-05-01 2014-03-26 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
CA2722427A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW200950780A (en) 2008-05-13 2009-12-16 Boehringer Ingelheim Int Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
JP5777030B2 (ja) 2008-07-25 2015-09-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 11β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤
RU2539979C2 (ru) 2008-07-25 2015-01-27 Вайтаи Фармасьютиклз, Инк. Циклические ингибиторы 11бета-гидроксистероид-дегидрогеназы 1
EP2350068B1 (en) 2008-10-23 2017-08-30 Boehringer Ingelheim International GmbH Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
CA2744946A1 (en) 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
UA109255C2 (ru) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
US8703765B2 (en) 2009-06-02 2014-04-22 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
EP2440537A1 (en) 2009-06-11 2012-04-18 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
WO2011002910A1 (en) 2009-07-01 2011-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
AR078887A1 (es) 2009-11-06 2011-12-07 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina y composiciones farmaceuticas que los contienen.
WO2011159760A1 (en) 2010-06-16 2011-12-22 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
EP2585444B1 (en) 2010-06-25 2014-10-22 Boehringer Ingelheim International GmbH Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
JP2013540801A (ja) 2010-11-02 2013-11-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 代謝異常の治療のための組合せ医薬
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
WO2013025664A1 (en) 2011-08-17 2013-02-21 Boehringer Ingelheim International Gmbh Indenopyridine derivatives

Also Published As

Publication number Publication date
DK108495C (da) 1967-12-27
DK108496C (da) 1967-12-27
CH449639A (de) 1968-01-15
CH449641A (de) 1968-01-15
NO119273B (OSRAM) 1970-04-27
FR4345M (OSRAM) 1966-08-16
DE1445853A1 (de) 1968-12-05
CH448118A (de) 1967-12-15
BE657405A (OSRAM) 1965-06-21
DK108497C (da) 1967-12-27
ES307299A1 (es) 1965-05-16
IL22643A (en) 1968-07-25
CH449642A (de) 1968-01-15
ES307301A1 (es) 1965-05-16
CH446371A (de) 1967-11-15
AT253687B (de) 1967-04-25
GB1077711A (en) 1967-08-02
AT249276B (de) 1966-09-12
NO119274B (OSRAM) 1970-04-27
BE657406A (OSRAM) 1965-06-21
IL22642A (en) 1968-07-25
AT249277B (de) 1966-09-12
DE1445854A1 (de) 1968-12-05
ES307300A1 (es) 1965-05-01
SE322779B (OSRAM) 1970-04-20
GB1092394A (en) 1967-11-22
NL6414820A (OSRAM) 1965-06-21
CH449640A (de) 1968-01-15
NL6414821A (OSRAM) 1965-06-21
CH449643A (de) 1968-01-15
FR4346M (OSRAM) 1966-08-16
NL127995C (OSRAM)
AT261126B (de) 1968-04-10
SE305657B (OSRAM) 1968-11-04
DK106552C (da) 1967-02-20

Similar Documents

Publication Publication Date Title
ES307302A1 (es) Procedimiento para preparar nuevos 6,7-benzomorfanos sustituidos.
ES301814A1 (es) Procedimiento para la obtencion de nuevos acidos aminicos.
ES320296A1 (es) Procedimiento para la preparacion de nuevos derivados del indol.
GB1098804A (en) Novel benzylmercaptans
ES396134A1 (es) Procedimiento para la preparacion de derivados de 1,1,1- tricloroetano.
ES326803A1 (es) Procedimiento para preparar agentes antiparasitarios.
ES320729A1 (es) Procedimiento para la sintesis de nuevos derivados de acido antranilico.
ES421182A1 (es) Procedimiento para preparar 1-fenoxi-3-fenoxi-etilamino-2- propanoles.
ES317623A1 (es) Un procedimiento para la preparacion de compuestos heterociclicos.
ES392699A1 (es) Procedimiento para la preparacion de nuevos derivados de triacina.
ES274334A1 (es) Procedimiento para la preparacion de nuevos compuestos de 1,4-benzodioxano
ES305739A1 (es) Procedimiento para la preparacion de nuevos 5-fenil-6,7-benzomorfanos sustituidos.
GB1044778A (en) Colour photography
GB1085997A (en) Manufacturing method of imidazolidinone derivatives
ES311200A1 (es) Procedimiento para la obtencion de compuestos piperacinicos.
GB1325944A (en) Bisoxalic acid diamides
ES393339A1 (es) Un procedimiento para la preparacion de derivados de nafto-quinona.
ES316622A1 (es) Procedimiento para la preparacion de derivados de acetofenona.
ES413742A1 (es) Un procedimiento para la preparacion de compuestos de acidol-alfa-hidrazino-betaf-fenilpropionico.
ES316075A1 (es) Procedimiento para la produccion de derivados del tropano.
ES301710A1 (es) Procedimiento para la preparación de nuevas 1,2-diaril-4-alquil-3,5-dioxo-pirazolidinas
ES292760A2 (es) Procedimiento de obtención de derivados de 4-aza-tia-xanteno
ES359770A1 (es) Procedimiento para preparar derivados de benzocicloheptano.
ES298095A1 (es) Procedimiento para la obtenciën de nuevos compuestos heterociclicos
ES272000A1 (es) Procedimiento para la preparación de nuevos derivados de cumarina